209 related articles for article (PubMed ID: 32127467)
21. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
[TBL] [Abstract][Full Text] [Related]
22. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
Stacchiotti S; Negri T; Zaffaroni N; Palassini E; Morosi C; Brich S; Conca E; Bozzi F; Cassinelli G; Gronchi A; Casali PG; Pilotti S
Ann Oncol; 2011 Jul; 22(7):1682-1690. PubMed ID: 21242589
[TBL] [Abstract][Full Text] [Related]
23. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; Laé M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
[TBL] [Abstract][Full Text] [Related]
24. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Judson I; Morden JP; Kilburn L; Leahy M; Benson C; Bhadri V; Campbell-Hewson Q; Cubedo R; Dangoor A; Fox L; Hennig I; Jarman K; Joubert W; Kernaghan S; López Pousa A; McNeil C; Seddon B; Snowdon C; Tattersall M; Toms C; Martinez Trufero J; Bliss JM
Lancet Oncol; 2019 Jul; 20(7):1023-1034. PubMed ID: 31160249
[TBL] [Abstract][Full Text] [Related]
25. Expression of MET in alveolar soft part sarcoma.
Jun HJ; Lee J; Lim DH; Park JO; Ahn G; Seo SW; Sung KS; Lim DH; Yoo KH; Choi YL
Med Oncol; 2010 Jun; 27(2):459-65. PubMed ID: 19472090
[TBL] [Abstract][Full Text] [Related]
26. Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip.
Chuaychob S; Lyu R; Tanaka M; Haginiwa A; Kitada A; Nakamura T; Yokokawa R
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2312472121. PubMed ID: 38502703
[TBL] [Abstract][Full Text] [Related]
27. A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
Li T; Wang L; Wang H; Zhang S; Atikan Kawuli ; Zhang X; Luo Z; Wang C
Invest New Drugs; 2016 Dec; 34(6):701-706. PubMed ID: 27604635
[TBL] [Abstract][Full Text] [Related]
28. Cheek alveolar soft part sarcoma recurrence at the primary site during follow-up: a case report and review of the literature.
An W; Xue Z; Zhuo H; Wang N; Meng L; Jia W
BMC Oral Health; 2024 Jun; 24(1):689. PubMed ID: 38872175
[TBL] [Abstract][Full Text] [Related]
29. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Wilky BA; Trucco MM; Subhawong TK; Florou V; Park W; Kwon D; Wieder ED; Kolonias D; Rosenberg AE; Kerr DA; Sfakianaki E; Foley M; Merchan JR; Komanduri KV; Trent JC
Lancet Oncol; 2019 Jun; 20(6):837-848. PubMed ID: 31078463
[TBL] [Abstract][Full Text] [Related]
30. A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.
Kim M; Kim TM; Keam B; Kim YJ; Paeng JC; Moon KC; Kim DW; Heo DS
Oncologist; 2019 Jan; 24(1):20-e29. PubMed ID: 30254189
[TBL] [Abstract][Full Text] [Related]
31. Alveolar soft-part sarcoma: a review and update.
Folpe AL; Deyrup AT
J Clin Pathol; 2006 Nov; 59(11):1127-32. PubMed ID: 17071801
[TBL] [Abstract][Full Text] [Related]
32. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report.
Xu Z; Zhang Y; Yu YH
Ann Palliat Med; 2021 Jan; 10(1):785-792. PubMed ID: 33545800
[TBL] [Abstract][Full Text] [Related]
34. Alveolar soft part sarcoma: a clinicopathological and immunohistochemical analysis of 26 cases emphasizing risk factors and prognosis.
Zhang Y; Huang Y; Qin Y; Yang N; Yang P; Li N; Feng Z
Diagn Pathol; 2024 Jan; 19(1):23. PubMed ID: 38291475
[TBL] [Abstract][Full Text] [Related]
35. Surgical management and outcome of spinal alveolar soft part sarcoma (ASPA): a case series of five patients and literature review.
Zhao C; Gao X; Yang J; Li Z; Cai X; Tan T; Hou T; Yan W; Yang X; Yang C; Liu T; Xiao J
World J Surg Oncol; 2017 Feb; 15(1):39. PubMed ID: 28166791
[TBL] [Abstract][Full Text] [Related]
36. Primary alveolar soft part sarcoma of the uterine cervix: a case report and literature review.
Feng M; Jiang W; He Y; Li L
Int J Clin Exp Pathol; 2014; 7(11):8223-6. PubMed ID: 25550876
[TBL] [Abstract][Full Text] [Related]
37. Primary alveolar soft part sarcoma of uterine corpus: a case report with immunohistochemical, ultrastructural study and review of literature.
Giordano G; D'Adda T; Varotti E; Crovini G; Silini EM
World J Surg Oncol; 2016 Feb; 14(1):24. PubMed ID: 26837430
[TBL] [Abstract][Full Text] [Related]
38. ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.
Kenney S; Vistica DT; Stockwin LH; Burkett S; Hollingshead MG; Borgel SD; Butcher DO; Schrump DS; Shoemaker RH
J Pediatr Hematol Oncol; 2011 Jul; 33(5):360-8. PubMed ID: 21552147
[TBL] [Abstract][Full Text] [Related]
39. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
Ye C; Wang J; Li W; Yuan M; Chai Y
Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
[TBL] [Abstract][Full Text] [Related]
40. Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma.
Kubota D; Yoshida A; Kawai A; Kondo T
J Proteome Res; 2014 May; 13(5):2250-61. PubMed ID: 24621013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
